Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,845.00    150.00 (2.24%)
Bid:
6,845.00
Ask:
6,850.00
Spread: 5.00 (0.073%)
Market Cap: £5.05b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Executive Director Promotion

20 Jul 2018 10:00

RNS Number : 2948V
Spirax-Sarco Engineering PLC
20 July 2018
 

 

 

News Release

 

20th July 2018

 

Executive Director Promotion

Strengthening of senior management team

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam, electrical thermal energy solutions, peristaltic pumping and associated fluid path technologies, is pleased to announce the following changes designed to strengthen the senior management team and support the continued development of the Group's successful businesses.

 

Neil Daws, Executive Director and Divisional Director currently responsible for the Group's Spirax Sarco Steam Specialties operations in Europe, Middle East and Africa (EMEA), is promoted to the position of Managing Director Steam Specialties Business, with effect from 1st September 2018. Neil will be responsible for all the Steam Specialties business worldwide, including Gestra, and will continue to report to the Group Chief Executive, Nicholas Anderson.

 

As a consequence of Neil's promotion, Sean Clay will join the Group on 30th July 2018 and assume the position of Divisional Director Spirax Sarco EMEA, with effect from 1st September 2018. Sean joins from Honeywell Group, the global Fortune 100 software-industrial company, where, over the last 14 years, he has held a number of roles with full P&L responsibility for international commercial and industrial businesses with revenues ranging from US$50 million to over US$1 billion. Sean will be based in Cheltenham and report to Neil Daws, holding an important role within the Steam Specialties' Executive team.

 

Commenting on Neil's and Sean's appointments, Nicholas Anderson, Group Chief Executive, said:

 

"The Spirax Sarco Group has grown considerably in recent years, both organically and through acquisitions. The integration of Aflex, Gestra and Chromalox, combined with continued growth of the core Spirax Sarco and Watson-Marlow businesses, has created a group with over £1 billion revenue and c. 7,400 employees.

 

Historically, Group Chief Executives have also occupied the position of Managing Director Steam Specialties Business. The Group's evolution in size and complexity makes this the right time to formally separate the two roles and put in place the appropriate organisational structure that will better support our Group's continued growth. Neil is extremely well qualified to take on his additional responsibility and I am delighted that he has agreed to this new challenge.

 

This appointment will allow me to spend more time on medium and longer term growth opportunities, including the further development of our Watson-Marlow and Chromalox businesses.

 

We also welcome Sean Clay to the Group. His considerable experience of international business operations and sales management will strengthen and enhance our senior management team.

 

Both of these appointments will promote our evolution as an organisation, enabling us to remain agile and responsive to the market opportunities ahead."

 

As a result of Neil Daws' additional responsibilities in this new role, his compensation has been reviewed by the Remuneration Committee. Neil's base salary will be increased by 10%, with all other elements of his current compensation remaining unchanged. This increase is compliant with the Group's 2017 Remuneration Policy.

 

There are no further disclosures to be made pursuant to Listing Rule 9.6.11.

 

Notes to Editors:

 

Biography of Neil Daws

Neil Daws, CEng, FIMechE, joined the Group in 1978 and held positions in manufacturing and design engineering prior to being named as UK Supply Director. Neil later held responsibility for Asia Pacific, Latin America and the Group's Supply operations, including the Group's Environmental Health and Safety matters. Neil was appointed to the Board in June 2003 and since September 2013, held the position of Divisional Director for Spirax Sarco EMEA.

 

Biography of Sean Clay

Sean joins Spirax Sarco from Honeywell Group, the global Fortune 100 software-industrial company, where, over the last 14 years, he held a number of roles with full P&L responsibility for commercial and industrial businesses with revenues ranging from US$50 million to over US$1 billion. Most recently, Sean was Chief Marketing Officer Honeywell Productivity Products and, prior to that, was President of Safety and Productivity Solutions, Europe. Sean holds a degree in Mechanical Engineering and Engineering Management, an MBA from the Cranfield School of Management (UK) and is a Chartered Fellow of the Institute of Directors (UK).

 

Enquiries:

Nicholas Anderson, Group Chief Executive

Tel: 01242 535234

 

Andy Robson, General Counsel

Tel: 01242 535276

 About Spirax Sarco

Spirax-Sarco Engineering plc comprises two world-leading businesses, Spirax Sarco for steam and electrical thermal energy solutions and Watson-Marlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies. Spirax Sarco provides a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The business helps its end users to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 7,400 people, of whom over 1,600 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

Further information can be found at www.spiraxsarcoengineering.com 

RNS filter: Inside information prior to release

LEI 213800WFVZQMHOZP2W17

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFMGZNRGNGRZG
Date   Source Headline
8th Jun 20261:24 pmRNSDirector/PDMR Shareholding
1st Jun 202610:28 amRNSChange in Major Shareholding
29th May 20262:24 pmRNSUpdate on Directorships held by Company Directors
27th May 20263:30 pmRNSDirector/PDMR Shareholding
26th May 20265:24 pmRNSDirector/PDMR Shareholding
19th May 20269:16 amRNSChange in Major Shareholding
14th May 20262:47 pmRNSExternal Directorships held by Company Directors
14th May 202610:39 amRNSDirector/PDMR Shareholding
13th May 20264:12 pmRNSResult of AGM
13th May 20267:00 amRNSTrading Update
8th May 20263:42 pmRNSChange in Major Shareholding
7th May 20269:03 amRNSDirector/PDMR Shareholding
8th Apr 20262:22 pmRNSDirector/PDMR Shareholding
8th Apr 20269:30 amRNSAnnual Report and Accounts 2025 and Notice of AGM
18th Mar 20264:53 pmRNSDirector/PDMR Shareholding
11th Mar 20261:53 pmRNSTotal Voting Rights
10th Mar 20265:01 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 Full Year Results
10th Mar 20267:00 amRNS2025 Full Year Results
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
10th Feb 20269:30 amRNSChange in Director Details
6th Feb 20263:47 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:50 pmRNSChange in Director Details
30th Jan 20262:19 pmRNSHolding(s) in Company
6th Jan 20263:10 pmRNSDirector/PDMR Shareholding
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 202510:34 amRNSBlocklisting Application
9th Dec 20252:35 pmRNSDirector/PDMR Shareholding
18th Nov 20259:40 amRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTrading Update
7th Nov 20251:56 pmRNSDirector/PDMR Shareholding
5th Nov 20258:39 amRNSHolding(s) in Company
22nd Oct 20257:00 amRNSBoard Appointment
7th Oct 20255:08 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNSDirector/PDMR Shareholding
1st Sep 20259:35 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSBoard Committee Membership Update
12th Aug 20257:00 amRNS2025 Half Year Results
7th Aug 20257:00 amRNSDirector/PDMR Shareholding
24th Jul 20254:58 pmRNSDirector/PDMR Shareholding
9th Jul 20254:26 pmRNSDirector/PDMR Shareholding
13th Jun 20253:36 pmRNSDirector/PDMR Shareholding
14th May 20254:48 pmRNSResult of AGM
14th May 20257:00 amRNSTrading Update
8th May 202511:03 amRNSDirector/PDMR Shareholding
23rd Apr 20255:13 pmRNSChange in Director Details
22nd Apr 20253:52 pmRNSDirector/PDMR Shareholding
11th Apr 20255:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.